MBRX Moleculin Biotech, Inc.

Healthcare

$2.45+2.51%ClosedMarket Cap: $3.0M

As of 2026-05-26

Analyst Consensus

Consensus

Buy

Target (Consensus)

$—

Target (Median)

$—

Target Range

$— - $—

1 Strong Buy2 Buy0 Hold0 Sell0 Strong Sell

Recent Analyst Ratings

Date	Firm	Action	Rating	Previous
2026-03-24	HC Wainwright & Co.	maintain	Buy	Buy
2025-12-11	HC Wainwright & Co.	maintain	Buy	Buy
2025-09-10	HC Wainwright & Co.	maintain	Buy	Buy
2025-06-18	HC Wainwright & Co.	maintain	Buy	Buy

Forward Estimates

Period	EPS Est.	Revenue Est.	# Analysts
Fri Dec 31	$-3.84	$42.0M	2
Sun Dec 31	$-3.56	$87.0M	2
Mon Dec 31	$0.96	$52.0M	1
Tue Dec 31	$5.86	$120.4M	1